Author

Milly Finch

Institution: Calderdale and Huddersfield NHS Foundation Trust

Observed institutions: Calderdale and Huddersfield NHS Foundation Trust, Sheffield Teaching Hospitals NHS Foundation Trust

ORCID: 0000-0001-7749-9530

Observed ORCID: 0000-0001-7749-9530

OpenAlex ID: A5032477535

Implications of parenteral chemotherapy dose standardisation in a tertiary oncology centre

2018 · Milly Finch, Neil Masters · Journal of Oncology Pharmacy Practice · 12

Implications of a technician-led pharmacy service on a day case unit in a tertiary oncology centre

2022 · Harriet Brown, Milly Finch · Journal of Oncology Pharmacy Practice · 2

Adjuvant olaparib real world data for BRCA positive, HER2-negative high-risk early breast cancer patients in the United Kingdom

2026 · Milly Finch, Carl Booth, et al. · Journal of Oncology Pharmacy Practice

Trends in preventative bone health measures in prostate cancer: A cross-sectional study of patients at Calderdale and Huddersfield NHS foundation trust

2025 · Milly Finch, Richard Jacques · Journal of Oncology Pharmacy Practice

Works count: 4

Citation count: 14

H-index: 2

I10-index: 1